Trustworthy Artificial Intelligence for Improvement of Stroke Outcomes

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Nov 26, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "Trustworthy Artificial Intelligence for Improvement of Stroke Outcomes," is exploring how artificial intelligence (AI) can help predict the recovery and long-term outcomes for patients who have suffered an ischemic stroke, which is caused by a blockage in blood flow to the brain. The researchers aim to develop AI tools that can provide accurate predictions about how well patients will recover based on their individual health data. This information could help doctors make better decisions about treatment and discharge plans, ultimately leading to improved care and reduced chances of having another stroke.

To participate in this study, you need to be at least 18 years old and diagnosed with an acute ischemic stroke. If you decide to join, you’ll provide consent and may be monitored through a combination of hospital visits and a mobile app designed for follow-up care. The study will collect data to train the AI models while keeping patient information private. Overall, the goal is to enhance communication and support for patients, helping them stick to prevention strategies after their stroke and improving their overall health outcomes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Subject is 18 years of age or older
• • 2. Diagnosis of acute ischemic stroke
• • 3. Signature of the informed consent form by the patient or a next of kin
• Exclusion Criteria:
• • No exclusion criteria are contemplated for this study.